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Abstract More than 10 years have passed since the
naming of periostin derived from its expression sites in the
periosteum and periodontal ligament. Following this ﬁnd-
ing, we have accumulated more data on the expression
patterns of periostin, and, ﬁnally, with the generation of
periostin-deﬁcient mice, have revealed functions of perio-
stin in the regeneration of tissues in bone, tooth, heart, and
skin, and its action in cancer invasion. Since periostin is a
matricellular protein, the ﬁrst investigation of periostin
function showed its enhancement of cell migration by
acting outside the cell. On the other hand, recent obser-
vations have demonstrated that periostin functions in
ﬁbrillogenesis in association with extracellular matrix
molecules inside the cell.
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Introduction
Periostin [1], a matricellular protein, was named based on
its expression in the periodontal ligament and periosteum
of adult mice. This protein was expected to function in
tooth and bone remodeling under mechanical stress, since
both the periodontal ligament and periosteum are sites
sensitive to mechanical stress by mastication and physical
exercise, respectively. Such stress induces remodeling
of the periodontal ligament and parietal bone. After
inﬂammation, the appearance of TGFb induces periostin
expression. Periostin, a 90-kDa secreted protein, has a
protein structure composed of an amino-terminal EMI
domain, a tandem repeat of 4 fas I domains, and a car-
boxyl-terminal domain including a heparin-binding site at
its C-terminal end (Fig. 1); therefore, we characterized it as
a member of the fasciclin I family based on these typical
fas I domains. Fasciclin I is a GPI-anchored Drosophila
protein containing 4 tandem fas I domains composed of
about 150 amino acid residues each, which are not related
to any other protein domain of known structures [2], and it
functions in axon growth guidance. In humans, fas I
domains are found in bigh3 [3] and stabilins [4] as well as
in periostin [5]. Periostin and bigh3 are most similar,
sharing uninterrupted tandem repeats of 4 fas I domains.
Interestingly, mutations in fas I domains of human bigh3
result in corneal dystrophy due to the deposition of insol-
uble protein aggregates in the cornea [6]. The EMI domain,
which is a small module rich in cysteine residues that is
found in the EMILIN family, is a site for protein–protein
interaction [7].
Periostin directly interacts with type I collagen [8–10],
ﬁbronectin [11] and Notch1 [12] through its EMI domain
and interacts with tenascin-C [11] and BMP-1 [13] through
its fas I domains. These periostin interactions with mainly
extracellular matrix (ECM) molecules ﬁrstly occur intra-
cellularly [11]. Furthermore, periostin serves as a ligand of
integrins such as avb3 and avb5 and promotes cell motility
[14] by acting outside the cell. In light of these properties
of protein interactions, I have classiﬁed periostin action
into two major functional categories, i.e., ﬁbrillogenesis,
which occurs inside the cell, and cell migration outside the
cell, involving its extracellular action.
After cloning the periostin gene, the establishment of 3
independent periostin-knockout mice provided the ﬁrst
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123insights into periostin function [8, 15–17]. These studies
demonstrated that periostin functions in regeneration of
tissues such as bone, tooth, and heart, and in cancer inva-
sion and wound healing.
Several reviews on the involvement of periostin in
cardiac development [18], tumorigenesis [19], and wound
healing [20] have already been published. Therefore, I
would like to focus on recent ﬁndings that support a new
concept of periostin function, i.e., its participation in
ﬁbrillogenesis.
Periostin in bone and ﬁbrillogenesis
From the initial stage of the periostin research, we expected
to ﬁnd that periostin functions in mechanical stress-induced
regeneration of periosteal bone. Periostin is speciﬁcally
expressed in the periosteum, which is a complex structure
composed of an outer ﬁbrous layer lending structural
integrity and an inner cambium layer possessing osteogenic
potential [21]. In periostin-deﬁcient mice, cortical bone in
the femur shows a decrease in area and thickness [11].
Moreover, ectopically mineralized deposits are observed in
periostin -/- mice following a thickening of the perios-
teum, which abnormal phenotype resembles periostitis. A
similar phenotype was observed in tenascin-C-deﬁcient
mice, suggesting that periostin is associated with tenascin-
C to elaborate an ECM meshwork architecture that
includes ﬁbronectin and type I collagen (Fig. 2). This
architecture generates a microenvironment for mechanical
stress-dependent bone formation. Consistently, we
observed reduced collagen cross-links for ﬁbrillogenesis in
the periosteum from periostin -/- femurs. Defective
cross-linkage is a common feature of periostin function
reported in periostin-deﬁcient mouse skin [10] and heart
tissues after a myocardial infarction [15].
The molecular mechanism of periostin action in colla-
gen cross-linking has been investigated, and the results
showed that periostin enhances the proteolytic activation of
lysyl oxidase (LOX), which is an enzyme responsible for
cross-link formation, and that it is caused by interacting
with BMP-1 to promote the collagen cross-linking [13]a s
shown in Fig. 3. In this activation of LOX, we propose the
involvement of a special ECM structure based on ﬁbro-
nectin to which precursor LOX and periostin can bind;
then, periostin stabilizes the precursor LOX to allow it to
be effectively proteolyzed to generate the mature LOX.
According to this scenario, periostin functions in high
stiffness collagen formation with effective collagen cross-
linking.
What is the molecular mechanism for generating this
collagen structure? In tendon, bone, and skin, type I col-
lagen is the major component of these ﬁbrils. In
ﬁbrillogenesis, collagen ﬁbril formation in cell culture is
dependent on the prior assembly of ﬁbronectin into ﬁbrils.
Therefore, collagen ﬁbrillogenesis that occurs on the cell
surface is downstream of ﬁbronectin assembly, and it is
mediated by interactions with cell-surface integrins [22].
Tenascin-C forms a typical disulﬁde-linked hexamer,
called the hexabrachion, in which six ﬂexible arms ema-
nate from a central globular particle, which possibly
catches and stabilizes a bifurcation of the ECM ﬁbrils
composed of ﬁbronectin and type I collagen to underlie
the extracellular meshwork architecture. Periostin and
A 90-kDa of TGFβ-induced secreted protein
EMI domain: binds to type I collagen, fibronectin and Notch1
Fas1 domain: binds to tenascin-C and BMP-1
C-terminal domain: splice variants and proteolytic cleavage
Properties of periostin protein
Periostin is a member of the fasciclinI family
Fig. 1 Properties of periostin protein. Periostin is a 90-kDa secreted
protein, and its expression is induced by TGFb. The protein structure
of periostin comprises an amino-terminal EMI domain, a tandem
repeat of 4 fas1 domains, and a carboxyl-terminal domain. From
conservation of the typical fas 1 domains, we characterized periostin
as being a member of the fasciclin I family, which includes bigh3 and
Drosophila fasciclin I. Periostin domains have the following charac-
teristics: the EMI domain binds to type I collagen, ﬁbronectin, and
Notch1; and the Fas I domains bind to tenascin-C and BMP-1. The









Fig. 2 Assembly between ﬁbronectin and tenascin-C by periostin.
Cleavage of the C-terminal end of perostin, including the heparin-
binding site (pink), can induce association of the truncated periostin
with tenascin-C via the fas I domains of periostin. Fibronectin is
associated with periostin at the EMI domain of the latter, and with
tenascin-c to form the speciﬁc hexabrachion structure, which behaves
as a scaffold, in which tenascin-C forms a disulﬁde-linked hexamer
(blue) that binds to the dimer form of ﬁbronectin (red) via periostin
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123tenascin-C expression are coordinately induced by
mechanical stress, with transcription of these genes being
regulated by cytoskeletal actin [23], indicating that perio-
stin-mediated incorporation of tenascin-C into the ECM
architecture maintains structural homeostasis when adapt-
ing to a changing mechanical environment.
Periostin in teeth
The ﬁrst observed phenotype of periostin -/- mice was
fragility of the teeth, mainly caused by defective peri-
odontal ligaments [8, 16]. Based on expression analysis of
periostin in embryonic teeth of the mouse mandible, the
periostin protein was localized to the interface between the
inner enamel epithelium and preodontoblasts as well as in
the mesenchymal tissues around the cervical loop [24]. In
juvenile mice at postnatal day 7, periostin protein is
restricted to the ﬁbrous bundles in the periodontal ligament
in accordance with the organization of periodontal ﬁbers
[24]. These ﬁndings suggest that periostin is involved at
sites of cell-to-matrix interaction, serving as adhesive
equipment for bearing mechanical forces including tooth
eruption, and transducing the occlusal force that activates
latent TGFb to enhance periostin expression [25]. Consis-
tently, periostin -/- mice show defective eruption of their
incisors [8] and degradation of the periodontal ligament of
molars during experimental tooth movement [12]. The
abnormal presence of non-digested collagen ﬁbrils in the
shear zone in the periostin -/- periodontal ligament [8]i s
now explained by the low activity of MMPs, which are
efﬁciently secreted following their induction by periostin
[26].
Periostin in mechanotransduction
It still remains to be investigated whether periostin is
directly connected with the mechanosensor. From the
speciﬁc expression of periostin in the periosteum and
periodontal ligament, we expected that periostin would be
linked to mechanical stress. To search for this linkage, we
looked for an upstream signal regulating periostin expres-
sion that would act in a transcriptional manner.
Investigating the periostin promoter, we found that twist, a
basic helix-loop-helix transcription factor, binds to up-
regulate its transcription [27]. To further demonstrate the
involvement of periostin and twist in mechanical stress, we
prepared an experimental model in which teeth were sub-
jected to movement. This forced mechanical stress up-
regulated periostin transcription [28]. In contrast, occlusal
hypofunction decreases the expression of both periostin
and twist [29]. Although the up-stream signals that regulate
twist remain unknown, periostin is very closely involved
with the mechanosensing signal. Analysis of the periostin
promoter sequences revealed predicted c-fos-binding sites,
which may provide for the ectopic expression of periostin
in the bone marrow of c-fos transgenic mice and in that of
patients with ﬁbrous dysplasia (FD) [30].
Speciﬁc transcription of the periostin gene in embryonic
fascias of muscles that receive mechanical stress in mice
provides further evidence of the involvement of periostin in
mechanical sensing [31]. Another animal model using
zebraﬁsh showed that periostin is expressed in the myo-
septum between muscles. This tissue senses mechanical
stress and delivers that signal from one muscle to another
[32]. The knock-down of periostin with morpholino anti-
sense oligonucleotide leads to defects in myoseptum
formation, a delay in the differentiation of myoﬁbers, and
disorder of the connection between myoﬁbrils and myo-
septum [32]. Similar to the myoseptum in zebraﬁsh,
tendons in mammals are a uniaxial connective tissue that
functions in the transmission of forces from the muscula-
ture to the skeletal system [33]. The relationship between
periostin and the mechanical integrity of tendons needs to
be further investigated.
In another study involving periostin in mechanotrans-















Fig. 3 Periostin function in
collagen cross-link formation.
Periostin recruits BMP-1 onto
the ﬁbronectin matrix to
enhance LOX activity for
collagen cross-linkage [13]
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123action of sclerostin, which is a receiver of bone-related
mechanical stress signals. Consequently, mechanical
stimuli have no effect on the skeletal properties in periostin
-/- mice [34]. All these results indicate that periostin is
very closely related to the mechanosensor.
Periostin in heart disease
Periostin is expressed in the heart valves throughout life
from embryo to adult. However, we could not observe any
signiﬁcant abnormalities in the formation of heart valves,
which would indicate that periostin mainly functions in
heart diseases in association with tissue repair. The
expression of periostin in the embryonic heart has already
been reviewed by Norris et al. [10]. Therefore, I will focus
here on periostin function in heart diseases.
In humans, periostin is abundantly expressed in the
infarct border after a myocardial infarction. In mice,
periostin expression is induced by TGFb following
inﬂammation at the infarct border [15]. To further study
these expression patterns, we assessed the regeneration of
heart tissues after a myocardial infarction in periostin -/-
mice [15]. Consistent with the ﬁndings made by Oka et al.
[17], we demonstrated that periosin functions in the
migration of cardiac ﬁbroblasts through engaging integrin
avb3, which induces phosphorylation of the downstream
kinase FAK (focal adhesion kinase), leading to the pro-
duction of type I collagen. Thereafter, periostin acts to
promote the collagen cross-linking in ECM. Interestingly,
one splice variant (DbDe: deletion of exons b and e at the 30
end of periostin mRNA) is preferentially expressed in
response to TGFb at the beginning of regeneration of heart
tissues and activates the integrin signals. This DbDe variant
form is also dominantly observed in the early stage of valve
development [26] and in periodontal tissues in mice [35].
In the later chronic stage of a myocardial infarction,
ﬁbrillogenesis is accelerated by periostin and proceeds to
generate a tight scar, in a similar fashion as in cardiac
hypertrophy [17]. Furthermore, in an experiment in which
rat cardiomyocytes were manipulated, Kuhn et al. [36]
showed that periostin induced the proliferation of differ-
entiated cardiomyocytes in the rat to improve ventricular
remodeling and myocardial infarction. However, this pro-
liferation was not observed in mice [37]. This discrepancy
needs to be resolved in the future.
The regulatory hierarchies active in the development of
cartilage, tendon, and bone are also important in heart
valve maturation and ECM remodeling. In diseased heart
valves, there is a distinct loss of ECM organization asso-
ciated with changes in mechanical properties that
ultimately lead to cardiac dysfunction [38]. In this respect,
periostin is a good candidate to be tested for involvement in
valve diseases. Hakuno et al. [26] reported that periostin
enhances the degeneration of atherosclerotic and rheumatic
cardiac valves. In mice fed with a high-fat diet, aortic valve
thickening and annular ﬁbrosis are increased, concomitant
with increased periostin expression, which is correlated
with tight scar formation after a myocardial infarction.
Periostin enhances ﬁbrillogenesis at the valve. Interest-
ingly, this report additionally found a new periostin
function, i.e., that periostin induces the secretion of MMP-
2 and MMP-9 from human epithelial cells and mouse
macrophages, respectively. This ﬁnding suggests that
periostin probably interacts with the precursor of MMP-2
or MMP-9 inside the cell for efﬁcient secretion following
proteolytic digestion to generate mature MMPs, which
scenario would be consistent with Notch1 maturation by
periostin after interaction of periostin and precursor Notch1
inside the cell [12].
Now, it is important to consider the two periostin
functions, cell migration outside the cell and ﬁbrillogenesis
through protein association inside the cell, separately in
heart diseases.
Periostin in tumor ﬁbrillogenesis
Although other functions of periostin in tumorigenesis have
been reviewed recently by Ruan et al. [19], I wish to
address a new concept regarding periostin in tumor ﬁbril-
logenesis. During tumorigenesis, periostin is a potential
contributor to tumor metastasis and epithelial–mesenchy-
mal transition (EMT). In colon cancer, periostin is
expressed in cancer-associated ﬁbroblasts [39], and in
pancreatic cancer, periostin is deposited in the periductal
stroma [40]. In these cancers, however, periostin expres-
sion is not observed in the cancer cells themselves.
In contrast, periostin plays a role as a suppressor of
invasion and metastasis in the progression of human
bladder cancers [41]. Our observations on cancer cells in
periostin -/- mice show the importance of endogenous
periostin in suppressing tumor size through activation of
ﬁbroblasts that produce ECM molecules for capsule for-
mation [42]. By considering different actions in tumor
malignancy, periostin-promoted cell migration or capsule
formation suppressing tumor growth, we can precisely
justify the periostin function in each tumor.
Actions of the C-terminal region of periostin
Alternative splicing at the 30 end of periostin generates 3
major variant forms: deletion of exon b, exon e, and exons
b and e (DbDe) in addition to the full form in mice. This
splicing event at the 30 end of periostin is evolutionarily
3204 A. Kudo
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an important function. The DbDe variant of periostin is
preferentially and commonly present in the periodontal
ligament, periosteum, and heart tissues after a myocardial
infarction. This form is also preferentially found in the
corresponding human tissues (unpublished data). The
major difference between the full form and the DbDe form
of periostin is recognizable at the moment of their secre-
tion. Although intact periostin is hardly secreted, the DbDe
form is effectively secreted, indicating that this variant
form is preferentially localized at the outside of cells and
on the ECM to interact with integrins. Myoﬁbroblasts
produce periostin, and they also express the splice variants
of ﬁbronectin and tenascin-C induced by the action of
TGFb, suggesting the presence of a functional complex
involving these three molecules. Han et al. [43] reported
that TGFb1 regulates ﬁbronectin isoform expression and
splicing factor SRp40 expression, suggesting the involve-
ment of a common splicing system in the same cell and
developmental stage that is organized by the same splicing
factor.
Periostin protein is often cleaved by proteolysis in heart
disease [15], periosteum [11], and during wound healing
[44]. This cleavage occurs preferentially from the C-ter-
minal end, although almost no functional observations
regarding cleaved truncated periostins were reported.
However, recently, we found that speciﬁc cleavage at a
region near the C-terminus of periostin, which is a heparin-
binding site [45], is essential for association of periostin
with tenascin-C [11], indicating that proteolytic cleavage is
functional in a developmental or pathological stage-
dependent manner. Further investigations regarding the
function of proteolytic cleavage of periostin are required.
Future perspective
In Fig. 4, I have summarized a mechanistic view of
periostin function. After inﬂammation or mechanical
stress, the expression of TGFb and/or IL-4 and IL-13 [9]i s
induced in macrophages and neutrophils (in response to
inﬂammation) or in other types of cells (in response to
mechanical stress). These cytokines trigger the expression
of periostin as well as primarily splice variants of other
ECM molecules (ﬁbronectin and tenascin-C) in ﬁbroblasts,
by acting through transcription factors such as twist and
c-fos. The splice variant of periostin is secreted and
localized outside the cell in the ECM, where it interacts
with integrin avb3 on myoﬁbroblasts to induce their cell
migration through downstream signals involving Akt and
FAK phosphorylation. These myoﬁbroblasts produce type I
collagen to repair tissues. In this collagen production,
periostin together with tenascin-C inside the cell forms a
meshwork structure with ﬁbronectin to constitute a scaffold
for the cross-linking of type I collagen. This cross-linking
is effected by periostin in association with BMP-1 to
activate lysyl oxidase for enhancement of cross-linking
activity inside the cell. During tissue repair, periostin helps
in the secretion of MMP-9 and expression of Notch1 on the
cell surface, which activities are probably regulated by the
association of precursor MMP-9 and Notch1 with periostin
for effective proteolysis by a furin-like proteinase to gen-
erate their secreted mature forms.
Regarding extracellular collagen ﬁbril growth after
secretion of the type I collagen meshwork, the initial stage
of ECM deposition results in arrays of narrow ﬁbrils of
uniform diameter, which diameter can increase by about
tenfold. In the ECM, collagen ﬁbril growth is thought to
occur by accretion as well as by lateral and end-to-end
fusion of collagen ﬁbrils [33]. Thus, we need to further
investigate the function of periostin in ﬁbrillogenesis out-
side the cell and the new possible functions of periostin
associated with matricellular proteins such as thrombo-
spondins and CCN family members in the ECM. In our
recent analysis, we found that periostin can associate with
CCN3 to function in periodontal ligament (Tanabe et al., in
preparation). Moreover, Hakuno et al. [26] have shown
























*TGFβ induces its alternative splicing.
** Periostininduces its secretion.
Fig. 4 Mechanistic view of periostin functions. Inﬂammation or
mechanical stress induces the expression of TGFb and/or IL-4 and IL-
13 in macrophages and neutrophils (for inﬂammation) or in other
types of cells (for mechanical stress). These cytokines then induce the
expression of periostin as well as that of other ECM molecules such
as ﬁbronectin and tenascin-C in ﬁbroblasts, which proteins are mainly
splice variants, by acting through transcription factors such as twist
and c-fos. The splice variant of periostin is secreted and localized
outside the cell in the ECM, where it interacts with integrin avb3o n
myoﬁbroblasts to induce their cell migration through downstream
signals of Akt and FAK phosphorylation. These myoﬁbroblasts
produce type I collagen to repair tissues. In this collagen production,
periostin together with tenascin-C inside the cell forms a meshwork
structure with ﬁbronectin to constitute a scaffold for the cross-linking
of type I collagen. This cross-linking is effected by periostin in
association with BMP-1 to activate lysyl oxidase (LOX) for
enhancement of cross-linking activity inside the cells. During tissue
repair, periostin helps in the secretion of MMP-9 and expression of
Notch1 on the cell surface
Periostin in ﬁbrillogenesis 3205
123some interesting data indicating overlapping expression of
periostin with elastin in the adult human cardiac valve,
suggesting the involvement of periostin in elastin cross-
linking outside the cell. Furthermore, in recent observa-
tions on periostin action outside the cell, periostin is found
to associate with laminin on the basement membrane in
hair follicles to induce keratinocyte proliferation during
wound healing [44].
Finally, regarding pathological ﬁbrillogenesis induced
by periostin, over-protective reactions by periostin in
pathogenesis accelerate ﬁbrillogenesis, which gives rise to
ﬁbrosis. In an experimental model of lung ﬁbrosis initiated
using bleomycin, a high expression of periostin is induced,
indicating a possible important action of periostin in tight
collagen ﬁber formation (Kondo et al., unpublished data).
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